Cited by 263Herpesvirus Infections and TreatmentsCytomegalovirus and herpesvirus researchAnimal Virus Infections Studies

The DOI matches its Crossref record; 297 of the 297 references it cites were found in a registry or an index.

Recent Progress in Herpes Simplex Virus Immunobiology and Vaccine Research

Open access

Koelle, David M., Corey, Lawrence·2003·Clinical Microbiology Reviews

DOI 10.1128/cmr.16.1.96-113.2003PMC PMC145296

Open this paper in CoChat — free account

Abstract

SUMMARY: Herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) cause prevalent, chronic infections that have serious outcomes in some individuals. Neonatal herpes may occur when the infant traverses the cervix during maternal genital herpes. Genital herpes is a major risk factor for human immunodeficiency virus type 1 transmission. Considerable efforts have been made to design and test vaccines for HSV, focusing on genital infection with HSV-2. Several protein subunit vaccines based on HSV-2 envelope glycoproteins have reached advanced-phase clinical trials. These antigens were chosen because they are the targets of neutralizing-antibody responses and because they elicit cellular immunity. Encouraging results have been reported in studies of treatment of HSV-seronegative women with a vaccine consisting of truncated glycoprotein D of HSV-2 and a novel adjuvant. Because most sexual HSV transmission occurs during asymptomatic shedding, it is important to evaluate the impact of vaccination on HSV-2 infection, clinically apparent genital herpes, and HSV shedding among vaccine recipients who acquire infection. There are several other attractive formats, including subunit vaccines that target cellular immune responses, live attenuated virus strains, and mutant strains that undergo incomplete lytic replication. HSV vaccines have also been evaluated for the immunotherapy of established HSV infection.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1128/cmr.16.1.96-113.2003

Cites

297 of 297 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Items 201–297 of 297

HveC (nectin-1) is expressed at high levels in sensory neurons, but not in motor neurons, of the rat peripheral nervous system
Mata, M. Z. M. (2001) · Journal of NeuroVirology · doi:10.1080/135502801753170336 · Cited by 58
Bystander activation of CD4+ T cells accounts for herpetic ocular lesions.
Gangappa, S., Deshpande, S. P., & Rouse, B. T. (2000) · PubMed · Cited by 57
Long Term Persistence of Herpes Simplex Virus-Specific CD8+ CTL in Persons with Frequently Recurring Genital Herpes
Posavad, C. M., Huang, M. L., Barcy, S., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.1146 · Cited by 57
Localization of the gD-Binding Region of the Human Herpes Simplex Virus Receptor, HveA
Whitbeck, J. C., Connolly, S. A., Willis, S. H., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.1.171-180.2001 · Cited by 56
Herpes simplex virus type 2 induces secretion of IL-12 by macrophages through a mechanism involving NF-κB
Malmgaard, L., Paludan, S. R., Mogensen, S. C., et al. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-12-3011 · Cited by 56
Early Intervention with High‐Dose Acyclovir Treatment during Primary Herpes Simplex Virus Infection Reduces Latency and Subsequent Reactivation in the Nervous System In Vivo
Sawtell, N. M., Thompson, R., Stanberry, L. R., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/323551 · Cited by 55
Protective T-Cell-Based Immunity Induced in Neonatal Mice by a Single Replicative Cycle of Herpes Simplex Virus
Franchini, M., Abril, C. E., Schwerdel, C., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.1.83-89.2001 · Cited by 54
Antigen‐Specific T Cells Localize to the Uterine Cervix in Women with Genital Herpes Simplex Virus Type 2 Infection
Koelle, D. M., Schomogyi, M., & Corey, L. (2000) · The Journal of Infectious Diseases · doi:10.1086/315749 · Cited by 54
Self-citation
Viral immune evasion strategies and the underlying cell biology
Lorenzo, M. E., Ploegh, H. L., & Tirabassi, R. S. (2001) · Seminars in Immunology · doi:10.1006/smim.2000.0290 · Cited by 53
Rapid epitope identification from complex class-II-restricted T-cell antigens
Kwok, W. W., Gebe, J. A., Liu, A. W., et al. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02038-5 · Cited by 53
Contemporary Approaches to Vaccination Against Herpes Simplex Virus
Burke, R. L. (1992) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-77247-4_9 · Cited by 53
Viral-Induced Leukocyte Interferon in Vesicle Fluid from Lesions of Recurrent Herpes Labialis
Overall, J. C., Spruance, S. L., & Green, J. A. (1981) · The Journal of Infectious Diseases · doi:10.1093/infdis/143.4.543 · Cited by 52
Disruption of Virion Host Shutoff Activity Improves the Immunogenicity and Protective Capacity of a Replication-Incompetent Herpes Simplex Virus Type 1 Vaccine Strain
Geiss, B. J., Smith, T. J., Leib, D. A., et al. (2000) · Journal of Virology · doi:10.1128/jvi.74.23.11137-11144.2000 · Cited by 52
A distinct population of nonphagocytic and low level CD4+ null lymphocytes produce IFN- alpha after stimulation by herpes simplex virus-infected cells.
Sandberg, K., Matsson, P., & Alm, G. V. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.3.1015 · Cited by 51
Immunoglobulin G, Plasma Cells, and Lymphocytes in the Murine Vagina after Vaginal or Parenteral Immunization with Attenuated Herpes Simplex Virus Type 2
Parr, E. L., & Parr, M. B. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.5137-5145.1998 · Cited by 51
Expression of TNF-α by Herpes Simplex Virus-Infected Macrophages Is Regulated by a Dual Mechanism: Transcriptional Regulation by NF-κB and Activating Transcription Factor 2/Jun and Translational Regulation Through the AU-Rich Region of the 3′ Untranslated Region
Paludan, S. R., Ellermann‐Eriksen, S., Kruys, V., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.2202 · Cited by 50
The Cutaneous Response in Humans to Treponema pallidum Lipoprotein Analogues Involves Cellular Elements of Both Innate and Adaptive Immunity
Sellati, T. J., Waldrop, S. L., Salazar, J. C., Bergstresser, P. R., Picker, L. J., & Radolf, J. D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.4131 · Cited by 49
Understanding the Pathogenesis of HSV-Associated Erythema multiforme
Aurelian, L., Kokuba, H., & Burnett, J. W. (1998) · Dermatology · doi:10.1159/000018000 · Cited by 49
Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus
Forrester, A., Sullivan, V., Simmons, A., et al. (1991) · Journal of General Virology · doi:10.1099/0022-1317-72-2-369 · Cited by 49
Herpes Simplex Inhibits the Capacity of Lymphoblastoid B Cell Lines to Stimulate CD4+ T Cells
Barcy, S., & Corey, L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.6242 · Cited by 49
Self-citation
Herpes Simplex Virus Type-2 Glycoprotein-Subunit Vaccine: Tolerance and Humoral and Cellular Responses in Humans
MERTZ, G. J., Peterman, G. M., Ashley, R. L., et al. (1984) · The Journal of Infectious Diseases · doi:10.1093/infdis/150.2.242 · Cited by 49
A comparison of biodegradable microparticles and MF59 as systemic adjuvants for recombinant gD from HSV-2
Singh, M. (1998) · Vaccine · doi:10.1016/s0264-410x(98)00179-0 · Cited by 48
HLA-unrestricted killing of HSV-1-infected mononuclear cells. Involvement of either gamma/delta+ or alpha/beta+ human cytotoxic T lymphocytes
Maccario, R., Revello, M. G., Comoli, P., et al. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.4.1437 · Cited by 47
Vaccine potential of a herpes simplex virus type 2 mutant deleted in the PK domain of the large subunit of ribonucleotide reductase (ICP10)
Aurelian, L. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00470-8 · Cited by 47
A combinatorial ledge: reverse transcriptase fidelity, total body viral burden, and the implications of multiple-drug HIV therapy for the evolution of antiviral resistance
Colgrove, R. C., & Japour, A. J. (1999) · Antiviral Research · doi:10.1016/s0166-3542(98)00062-x · Cited by 46
Immunization with a LEAPS™ heteroconjugate containing a CTL epitope and a peptide from beta-2-microglobulin elicits a protective and DTH response to herpes simplex virus type 1
Rosenthal, K. S., Mao, H., Horne, W. I., et al. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00231-x · Cited by 46
Oral transgene vaccination mediated by attenuated Salmonellae is an effective method to prevent Herpes simplex virus-2 induced disease in mice
Fló, J., Tisminetzky, S. G., & Baralle, F. E. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00375-3 · Cited by 45
Clinical efficacy of a herpes simplex subunit vaccine
Cappel, R., Sprecher, S., de Cuyper, F., et al. (1985) · Journal of Medical Virology · doi:10.1002/jmv.1890160206 · Cited by 45
A growth and latency compromised herpes simplex virus type 2 mutant (ICP10ΔPK) has prophylactic and therapeutic protective activity in guinea pigs
Wachsman, M., Kulka, M., Smith, C. C., & Aurelian, L. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00446-1 · Cited by 45
Vaccination with a cocktail of seven recombinantly expressed HSV-1 glycoproteins protects against ocular HSV-1 challenge more efficiently than vaccination with any individual glycoprotein
Ghiasi, H., Nesburn, A. B., & Wechsler, S. L. (1996) · Vaccine · doi:10.1016/0264-410x(95)00169-2 · Cited by 45
Helper activity in antigen-specific antibody production mediated by CD4+ human cytotoxic T cell clones directed against herpes simplex virus.
Yasukawa, M., Inatsuki, A., & Kobayashi, Y. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.10.3419 · Cited by 44
Th1Th2-like immunity and resistance to herpes simplex labialis
Spruance, S. L., Evans, T. G., McKeough, M. B., Thai, L., Araneo, B. A., Daynes, R. A., Mishkin, E. M., & Abramovitz, A. S. (1995) · Antiviral Research · doi:10.1016/0166-3542(95)00037-m · Cited by 44
Analysis of herpes simplex virus 1 and 2 infection in women with high risk sexual behaviour in Mexico
Conde-Glez, C. J., Juárez-Figueroa, L. A., Uribe-Salas, F. J., et al. (1999) · International Journal of Epidemiology · doi:10.1093/ije/28.3.571 · Cited by 44
The three HveA receptor ligands, gD, LT-α and LIGHT bind to distinct sites on HveA
Sarrias, M., Whitbeck, J. C., Rooney, I. A., et al. (2000) · Molecular Immunology · doi:10.1016/s0161-5890(00)00089-4 · Cited by 43
Humoral immune response to herpes simplex virus type 2 glycoproteins in patients receiving a glycoprotein subunit vaccine
Ashley, R. L., MERTZ, G. J., Clark, H., et al. (1985) · Journal of Virology · doi:10.1128/jvi.56.2.475-481.1985 · Cited by 42
Virus-Cell Interactions Regulating Induction of Tumor Necrosis Factor Alpha Production in Macrophages Infected with Herpes Simplex Virus
Paludan, S. R., & Mogensen, S. C. (2001) · Journal of Virology · doi:10.1128/jvi.75.21.10170-10178.2001 · Cited by 42
CD4 T-Cell Responses to Herpes Simplex Virus Type 2 Major Capsid Protein VP5: Comparison with Responses to Tegument and Envelope Glycoproteins
Koelle, D. M., Schomogyi, M., McClurkan, C. L., et al. (2000) · Journal of Virology · doi:10.1128/jvi.74.23.11422-11425.2000 · Cited by 42
Self-citation
Immunization with Chaperone-Peptide Complex Induces Low-Avidity Cytotoxic T Lymphocytes Providing Transient Protection against Herpes Simplex Virus Infection
Kumaraguru, U., Gieryńska, M. M., Norman, S., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.1.136-141.2002 · Cited by 41
Herpes simplex virus (HSV)-specific proliferative and cytotoxic T-cell responses in humans immunized with an HSV type 2 glycoprotein subunit vaccine
Zarling, J. M., Moran, P. A., Brewer, L. A., et al. (1988) · Journal of Virology · doi:10.1128/jvi.62.12.4481-4485.1988 · Cited by 40
Changes in Prevalence of Herpes Simplex Virus Type 1 and 2 Antibodies from 1973 to 1993 in the Rural Districts of Japan
Hashido, M., Kawana, T., Matsunaga, Y., et al. (1999) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1999.tb02390.x · Cited by 40
Analysis of DNA From Recurrent Genital Herpes Simplex Virus Isolates by Restriction Endonuclease Digestion
Lakeman, A. D., Nahmias, A. J., & Whitley, R. J. (1986) · Sexually Transmitted Diseases · doi:10.1097/00007435-198604000-00001 · Cited by 39
Vaccination against Herpes Simplex Virus Infections
Meignier, B. (1985) · Springer eBooks · doi:10.1007/978-1-4615-8021-8_13 · Cited by 38
Immunogenicity in mice of tandem repeats of an epitope from herpes simplex gD protein when expressed by recombinant adenovirus vectors
Zheng, B., Graham, F. L., Johnson, D. C., et al. (1993) · Vaccine · doi:10.1016/0264-410x(93)90042-v · Cited by 38
The quest for a herpes simplex virus vaccine: background and recent developments
Hall, M. J., & Katrak, K. (1986) · Vaccine · doi:10.1016/0264-410x(86)90001-0 · Cited by 37
The Immune Response Modifier Imiquimod Requires STAT-1 for induction of Interferon, Interferon-Stimulated Genes, and Interleukin-6
Bottrel, R. L. A., Yang, Y., Levy, D. E., Tomai, M. A., & Reis, L. F. L. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.856 · Cited by 36
Presence or absence of TGF-beta determines IL-4-induced generation of type 1 or type 2 CD8 T cell subsets.
Erard, F., García‐Sanz, J. A., Moriggl, R., & Wild, M.-T. (1999) · PubMed · Cited by 36
The efficacy and safety of Skinner herpes simplex vaccine towards modulation of herpes genitalis; report of a prospective double-blind placebo-controlled trial
Skinner, G. R. B., Turyk, M. E., Benson, C. A., et al. (1997) · Medical Microbiology and Immunology · doi:10.1007/s004300050043 · Cited by 36
Varicella Vaccine: Genesis, Efficacy, and Attenuation
Arvin, A. M. (2001) · Virology · doi:10.1006/viro.2001.0918 · Cited by 36
Limited Variability of Glycoprotein Gene Sequences and Neutralizing Targets in Herpes Simplex Virus Type 2 Isolates and Stability on Passage in Cell Culture
Terhune, S. S., Coleman, K. T., Sekulovich, R. E., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/515590 · Cited by 36
Prospects for a vaccine against herpes simplex virus types 1 and 2.
Dix, R. (1987) · PubMed · Cited by 36
Presence or Absence of TGF-β Determines IL-4-Induced Generation of Type 1 or Type 2 CD8 T Cell Subsets
Erard, F., García‐Sanz, J. A., Moriggl, R., & Wild, M.-T. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.209 · Cited by 36
Protection by minigenes: a novel approach of DNA vaccines
Zhiya, Y. (1998) · Vaccine · doi:10.1016/s0264-410x(98)00065-6 · Cited by 33
Chronic lymphocytic leukemia B cells are highly sensitive to infection by herpes simplex virus-1 via herpesvirus-entry-mediator A
Eling, D. J., Johnson, P., Sharma, S. K., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301241 · Cited by 33
Antibody Response and Protective Capacity of Plasmid Vaccines Expressing Three Different Herpes Simplex Virus Glycoproteins
Nass, P. H., Elkins, K. L., & Weir, J. P. (1998) · The Journal of Infectious Diseases · doi:10.1086/515374 · Cited by 33
Demonstration of either endogenous recurrence or exogenous reinfection by resiriction endonuclease cleavage analysis of herpes simplex virus from patients with recrudescent genital herpes
Sakaoka, H., Aomori, T., Gouro, T., et al. (1995) · Journal of Medical Virology · doi:10.1002/jmv.1890460416 · Cited by 32
Effect of route of vaccination with vaccinia virus expressing HSV-2 glycoprotein D on protection from genital HSV-2 infection
Bernstein, D. I. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00416-8 · Cited by 32
Current developments in herpes simplex virus vaccines
Burke, R. L. (1993) · Seminars in Virology · doi:10.1006/smvy.1993.1014 · Cited by 31
Cervical Antibody Responses to a Herpes Simplex Virus Type 2 Glycoprotein Subunit Vaccine
Ashley, R. L., Crisostomo, F.-M., Doss, M., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/515611 · Cited by 30
Intraocular T Cells of Patients with Herpes Simplex Virus (HSV)–Induced Acute Retinal Necrosis Recognize HSV Tegument Proteins VP11/12 and VP13/14
Verjans, G. M. G. M., Dings, M. E. M., McLauchlan, J., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315759 · Cited by 29
Precipitous clearance of herpes simplex virus antigens from the peripheral nervous systems of experimentally infected C57BL/10 mice.
Speck, P. G., & Simmons, A. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-3-561 · Cited by 29
Herpes simplex virus antigens and inflammatory cells in oral lesions in recurrent erythema multiforme. Immunoperoxidase and autoradiographic studies.
Malmström, M., Ruokonen, H., Konttinen, Y. T., et al. (1990) · Acta Dermato Venereologica · doi:10.2340/0001555570405410 · Cited by 29
Native and recombinant herpes simplex virus type 1 envelope proteins induce human immune T-lymphocyte responses
Torseth, J. W., Cohen, G. H., Eisenberg, R. J., et al. (1987) · Journal of Virology · doi:10.1128/jvi.61.5.1532-1539.1987 · Cited by 28
Immunogenicity of Herpes Simplex Virus Type 1 Mutants Containing Deletions in One or More α-Genes: ICP4, ICP27, ICP22, and ICP0
Brehm, M. A., Samaniego, L. A., Bonneau, R. H., et al. (1999) · Virology · doi:10.1006/viro.1999.9653 · Cited by 28
The Large Subunit of Herpes Simplex Virus Type 2 Ribonucleotide Reductase (ICP10) Is Associated with the Virion Tegument and Has PK Activity
Smith, C. C., & Aurelian, L. (1997) · Virology · doi:10.1006/viro.1997.8645 · Cited by 27
Herpes Simplex Virus Virion Host Shutoff Protein Requires a Mammalian Factor for Efficient In Vitro Endoribonuclease Activity
Lu, P., Jones, F. E., Saffran, H. A., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.3.1172-1185.2001 · Cited by 27
Molecular characterisation of HCV genotype 4 isolates circulating in Italy
Argentini, C., Dettori, S., Villano, U., Guadagnino, V., Infantolino, D., Dentico, P., Coppola, R., & Rapicetta, M. (2000) · Journal of Medical Virology · doi:10.1002/1096-9071(200009)62:1 · Cited by 27
How Do CTL Control Virus Infections? Evidence for Prelytic Halt of Herpes simplex
Martz, E., & Gamble, S. (1992) · Viral Immunology · doi:10.1089/vim.1992.5.81 · Cited by 26
Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets.
Maccario, R., Comoli, P., Percivalle, E., et al. (1995) · PubMed · Cited by 25
A Novel Gene Expressed in Human Keratinocytes with Long-Term In Vitro Growth Potential is Required for Cell Growth
Aurelian, L., Smith, C. C., Winchurch, R. A., et al. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.00191.x · Cited by 24
A First Step toward Understanding Membrane Fusion Induced by Herpes Simplex Virus
Spear, P. G. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00289-1 · Cited by 24
Pathogenesis of acyclovir-resistant herpes simplex type 2 isolates in animal models of genital herpes: models for antiviral evaluations
Bernstein, D. I., IRELAND, J., & Bourne, N. K. (2000) · Antiviral Research · doi:10.1016/s0166-3542(00)00104-2 · Cited by 23
Herpes simplex virus type 1-specific immunity induced by peptides corresponding to an antigenic site of glycoprotein B
Mester, J. C., Highlander, S. L., Osmand, A. P., et al. (1990) · Journal of Virology · doi:10.1128/jvi.64.11.5277-5283.1990 · Cited by 22
Longitudinal Study of a Patient with Herpes-simplex-Virus-Associated Erythema multiforme: Viral Gene Expression and T Cell Repertoire Usage
Kokuba, H., Imafuku, S., Jw, B., & Aurelian, L. (1999) · Dermatology · doi:10.1159/000018121 · Cited by 22
Inhibition of Herpes Simplex Virus Replication in vitro by Human Cytotoxic T Cell Clones and Natural Killer Cell Clones
Yasukawa, M., & Kobayashi, Y. (1985) · Journal of General Virology · doi:10.1099/0022-1317-66-10-2225 · Cited by 22
Cervical antibodies in patients with oral herpes simplex virus type 1 (HSV-1) infection: local anamnestic responses after genital HSV-2 infection
Ashley, R. L., Wald, A., & Corey, L. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.5284-5286.1994 · Cited by 22
Self-citation
Herpes simplex virus type 2 unique biological properties include neoplastic potential mediated by the Pk domain of the large subunit of ribonucleotide reductase
Aurelian, L. (1998) · Frontiers in bioscience · doi:10.2741/a238 · Cited by 21
The effect of light on poliovirus grown in neutral red
Wilson, J. N., & Cooper, P. D. (1965) · Virology · doi:10.1016/0042-6822(65)90019-x · Cited by 21
Cell-mediated immunity against herpes simplex virus envelope, capsid, excreted, and crude antigens
Kalimo, K., Joronen, I., & Havu, V. K. (1983) · Infection and Immunity · doi:10.1128/iai.39.1.24-28.1983 · Cited by 20
Role of Coexpression of IL-2 and Herpes Simplex Virus Proteins in Recombinant Vaccinia Virus Vectors on Levels of Induced Immunity
Allen, E. M., Weir, J. P., Martin, S. J., et al. (1990) · Viral Immunology · doi:10.1089/vim.1990.3.207 · Cited by 19
Epitopes of Herpes Simplex Virus Type 1 Glycoprotein B that Bind Type-Common Neutralizing Antibodies Elicit Type-Specific Antibody-Dependent Cellular Cytotoxicity
Sanchez-Pescador, L., Paz, P., Navarro, D., et al. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/166.3.623 · Cited by 19
Multicentre Clinical Trial with Herpes Simplex Virus Vaccine in Recurrent Herpes Infection
Mastrolorenzo, A., Tiradritti, L., Salimbeni, L., et al. (1995) · International Journal of STD & AIDS · doi:10.1177/095646249500600611 · Cited by 19
Clinical and Laboratory Study of First Episode Genital Herpes in Singapore
Cheong, W. K., Thirumoorthy, T., Doraisingham, S., et al. (1990) · International Journal of STD & AIDS · doi:10.1177/095646249000100309 · Cited by 18
Improving DNA Vaccines Targeting Viral Infection
Sin, J., & Weiner, D. B. (2000) · Intervirology · doi:10.1159/000053991 · Cited by 18
Natural infection with herpes simplex virus type 1 (HSV-1) induces humoral and T cell responses to the HSV-1 glycoprotein H:L complex
Westra, D. F., Verjans, G. M. G. M., Osterhaus, A. D. M. E., et al. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-8-2011 · Cited by 18
Search for Polymorphisms in the Genes for Herpesvirus Entry Mediator, Nectin‐1, and Nectin‐2 in Immune Seronegative Individuals
Struyf, F., Posavad, C. M., Keyaerts, E., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/338116 · Cited by 16
Mice Genetic Immunization with Plasmid DNA Encoding a Secreted Form of HSV-1 gB Induces a Protective Immune Response against Herpes simplex Virus Type 1 Infection
Caselli, E., Grandi, P., Argnani, R., et al. (2001) · Intervirology · doi:10.1159/000050023 · Cited by 14
Inhibition of Herpes Simplex Virus gD and Lymphotoxin-α Binding to HveA by Peptide Antagonists
Sarrias, M., Whitbeck, J. C., Rooney, I. A., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5681-5687.1999 · Cited by 13
Characterization of T cell responses to herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2) using a TNF-β ELISpot cytokine assay
Schmid, D. S., THIEME, M. L., Gary, H. E., et al. (1997) · Archives of Virology · doi:10.1007/s007050050187 · Cited by 11
Restriction enzyme fragment length polymorphisms of amplified herpes simplex virus type-1 DNA provide epidemiologic information
Haugen, T. H., Alden, B., Matthey, S., et al. (1993) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(93)90023-z · Cited by 10
Domains of Glycoprotein H of Herpes Simplex Virus Type 1 Involved in Complex Formation with Glycoprotein L
Westra, D. F., Kuiperij, H. B., Welling, G. W., et al. (1999) · Virology · doi:10.1006/viro.1999.9860 · Cited by 10
The effect of human T cell leukaemia virus type I infection on a herpes simplex virus‐specific CD8+ cytotoxic T cell clone
Inatsuki, A., Yasukawa, M., & Kobayashi, Y. (1991) · British Journal of Haematology · doi:10.1111/j.1365-2141.1991.tb08576.x · Cited by 7
Prevention of herpes genitalis by the 'Bulgarian' vaccine F.HSV-2V(PRK): preliminary clinical evidence.
Skinner, G. R. B., Davies, J. A., Dundarov, S., et al. (2000) · PubMed · Cited by 5
Herpesviruses as unrecognised components of the pathogenesis of chronic diseases
Griffiths, P. D. (2000) · Reviews in Medical Virology · doi:10.1002/1099-1654(200009/10)10:5 · Cited by 3
Generation of a primary immune response to a genetically Inactivated (DISC) herpes simplex virus and wild type virus
Hill, S., Zhang, X., Boursnell, M. E. G., et al. (1997) · Biochemical Society Transactions · doi:10.1042/bst025200s · Cited by 3
Intratypic Variations in Neutralizable Epitopes among Herpes Simplex Virus Type 2 Isolates
Bhattarakosol, P., Yoosook, C., & Matangkasombut, P. (1991) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1991.tb01583.x · Cited by 2
The Use of Muramyl Peptides as Vaccine Adjuvants
Ott, G. S., Nest, G. V., & Burke, R. L. (2024) · CRC Press eBooks · doi:10.1201/9781003573838-5 · Cited by 2
Short peptides sensitize target cells to CTL specific for the MHC class Ib molecule, H2-M3
Dabhi, V. M., & Fischer Lindahl, K. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199811)28:11

Research works printed but not linked: 2

Corey L. and A. Wald. 1999. Genital herpes p. 285-312. In K. K. Holmes P. F. Sparling P. A. Mardh S. M. Lemon W. E. Stamm P. Piot and J. M. Wasserheit (ed.) Sexually transmitted diseases 3rd ed. McGraw-Hill Inc. New York N.Y.
Roizman B. and P. E. Pellett. The family herpesviridae: a brief introduction p. 2381-2397. In D. M. Knipe P. M. Howley and D. E. Griffin (ed.) Fields virology 4th ed. vol. 2. Lippincott Philadelphia Pa.

Sorted by citations

Viral Vector Systems for Gene Therapy: A Comprehensive Literature Review of Progress and Biosafety Challenges
Ghosh, S., Brown, A. M., Jenkins, C., & Campbell, K. (2020) · Applied Biosafety · doi:10.1177/1535676019899502 · Cited by 218
The Acquired Immune System
Hedrick, S. M. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.020 · Cited by 122
Sustained elevation of kynurenic Acid in the cerebrospinal fluid of patients with herpes simplex virus type 1 encephalitis
Atlas, A., Franzen-Röhl, E., Söderlund, J., Jönsson, E. G., Samuelsson, M., Schwieler, L., Sköldenberg, B., & Engberg, G. (2013) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s13256 · Cited by 25

See all 263

Authors: Koelle, D. M., & Corey, L.
Affiliations: University of Washington (US)
Corresponding author: Koelle, David M.
ORCID: Koelle, David M.
Corey, Lawrence
Venue: Clinical Microbiology Reviews
Publisher: American Society for Microbiology
Published: 2003-01
Volume: 16
Issue: 1
Pages: 96-113
ISSN: 0893-8512 (ISSN-L)
1098-6618
DOI: 10.1128/cmr.16.1.96-113.2003
PMC: PMC145296
OpenAlex: W2158636026
Cited by: 263
References: 297
Citations by year: 2026: 3 · 2025: 2 · 2024: 6 · 2023: 5 · 2022: 6 · 2020: 5 · 2019: 5 · 2018: 3 · 2017: 10 · 2016: 7 · 2015: 13 · 2014: 10 · 2013: 12 · 2012: 16
FWCI: 3.16
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Clinical Microbiology Reviews (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of Allergy and Infectious Diseases (R21AI050132, AI 30731, P01AI030731, R01AI050132, AI 50132)
Topics: Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
Keywords: herpes simplex virus, herpes simplex virus type 1, herpes simplex virus type 2, herpes vaccine, subunit vaccine, glycoproteins, glycoprotein D, adjuvants, genital herpes, neonatal herpes, HIV transmission, asymptomatic viral shedding, live attenuated vaccine, cell-mediated immunity, neutralizing antibodies
MeSH terms: Forecasting, Herpes Simplex, Humans, Viral Vaccines, Simplexvirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Recent Progress in Herpes Simplex Virus Immunobiology and Vaccine Research

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks